Newsletter
#32 Payal from .406 Ventures on Investing in Healthcare Technology

The Redox Podcast

#32 Payal from .406 Ventures on Investing in Healthcare Technology

November 24, 2020

#32 Payal from .406 Ventures on Investing in Healthcare Technology

On today’s show we have Payal Agrawal Divakaran. She leads digital health investments as a partner at .406 Ventures in Boston who was, of course, the first institutional investor to bet on Redox, leading our Series A back in October of 2015. We discuss some of her journey as well as where she’s making (and has made) bets in healthcare technology. This includes Redox, AristaMD, Heartbeat Health, WellbeHealth, and Axial. We also discuss areas where she has an active thesis and is looking for investments. 

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

Proudly supported by:

cover
Episode #123 – Is It Getting Worse to Be a Nurse? John and David tackle the shortage, while exploring the implications it can have for our healthcare system as a whole.